A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.Joseph P. Eder, Donald Küfe, Glenn J. Bubley et al.|PubMed|2000Cited by 296
A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primateJames W. Hodge, Judy Kantor, Jeffrey Schlom et al.|International Journal of Cancer|1995Cited by 106